Lo-Coco F - Search Results

1

In vitro all-trans retinoic acid sensitivity of acute myeloid leukemia blasts with NUP98/RARG fusion gene.

Such E, Cordón L, Sempere A, Villamón E, Ibañez M, Luna I, Gómez-Seguí I, López-Pavía M, Alonso C, Lo-Coco F, Cervera J, Sanz MA. Such E, et al. Ann Hematol. 2014 Nov;93(11):1931-3. doi: 10.1007/s00277-014-2073-5. Epub 2014 Apr 13. Ann Hematol. 2014. PMID: 24728721 No abstract available.

2

Choice of chemotherapy in induction, consolidation and maintenance in acute promyelocytic leukaemia.

Sanz MA, Martín G, Lo Coco F. Sanz MA, et al. Best Pract Res Clin Haematol. 2003 Sep;16(3):433-51. doi: 10.1016/s1521-6926(03)00040-9. Best Pract Res Clin Haematol. 2003. PMID: 12935961 Review.

3

Tricks of the trade for the appropriate management of newly diagnosed acute promyelocytic leukemia.

Sanz MA, Tallman MS, Lo-Coco F. Sanz MA, et al. Blood. 2005 Apr 15;105(8):3019-25. doi: 10.1182/blood-2004-09-3475. Epub 2004 Dec 16. Blood. 2005. PMID: 15604216 Free article. Review.

4

Standard practice and controversial issues in front-line therapy of acute promyelocytic leukemia.

Sanz MA, Lo Coco F. Sanz MA, et al. Haematologica. 2005 Jun;90(6):840-5. Haematologica. 2005. PMID: 15951298 Review.

5

Practice points, consensus, and controversial issues in the management of patients with newly diagnosed acute promyelocytic leukemia.

Sanz MA, Tallman MS, Lo-Coco F. Sanz MA, et al. Oncologist. 2005 Nov-Dec;10(10):806-14. doi: 10.1634/theoncologist.10-10-806. Oncologist. 2005. PMID: 16314291 Free article. Review.

6

FLT3 inhibition as a targeted therapy for acute myeloid leukemia.

Sanz M, Burnett A, Lo-Coco F, Löwenberg B. Sanz M, et al. Curr Opin Oncol. 2009 Nov;21(6):594-600. doi: 10.1097/CCO.0b013e32833118fd. Curr Opin Oncol. 2009. PMID: 19684517 Review.

7

Modern approaches to treating acute promyelocytic leukemia.

Sanz MA, Lo-Coco F. Sanz MA, et al. J Clin Oncol. 2011 Feb 10;29(5):495-503. doi: 10.1200/JCO.2010.32.1067. Epub 2011 Jan 10. J Clin Oncol. 2011. PMID: 21220600 Review.

8

Analysis of mutational status, SNP rs16754, and expression levels of Wilms tumor 1 (WT1) gene in acute promyelocytic leukemia.

Gaur GC, Ramadan SM, Cicconi L, Noguera NI, Luna I, Such E, Lavorgna S, Di Giandomenico J, Sanz MA, Lo-Coco F. Gaur GC, et al. Ann Hematol. 2012 Dec;91(12):1855-60. doi: 10.1007/s00277-012-1546-7. Epub 2012 Aug 16. Ann Hematol. 2012. PMID: 22895555

9

Biology and management of therapy-related acute promyelocytic leukemia.

Lo-Coco F, Hasan SK, Montesinos P, Sanz MA. Lo-Coco F, et al. Curr Opin Oncol. 2013 Nov;25(6):695-700. doi: 10.1097/CCO.0000000000000013. Curr Opin Oncol. 2013. PMID: 24076582 Review.

10

All-trans retinoic acid with daunorubicin or idarubicin for risk-adapted treatment of acute promyelocytic leukaemia: a matched-pair analysis of the PETHEMA LPA-2005 and IC-APL studies.

Sanz MA, Montesinos P, Kim HT, Ruiz-Argüelles GJ, Undurraga MS, Uriarte MR, Martínez L, Jacomo RH, Gutiérrez-Aguirre H, Melo RA, Bittencourt R, Pasquini R, Pagnano K, Fagundes EM, Vellenga E, Holowiecka A, González-Huerta AJ, Fernández P, De la Serna J, Brunet S, De Lisa E, González-Campos J, Ribera JM, Krsnik I, Ganser A, Berliner N, Ribeiro RC, Lo-Coco F, Löwenberg B, Rego EM; IC-APL and PETHEMA and HOVON Groups. Sanz MA, et al. Ann Hematol. 2015 Aug;94(8):1347-56. doi: 10.1007/s00277-015-2393-0. Epub 2015 May 15. Ann Hematol. 2015. PMID: 25975975 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

462 results

Search Page